Virtus ETFs > ETFis Series Trust I
Virtus LifeSci Biotech Products ETF
$17.20M
Avg Monthly Net Assets
$22.57M
Total Assets
$577K
Total Liabilities
$22.00M
Net Assets
Virtus LifeSci Biotech Products ETF is an Exchange-Traded Fund in ETFis Series Trust I
from Virtus ETFs,
based in New York,
United States of America.
The fund has one share class
and monthly net assets of $17.20M.
On September 27th, 2024 it reported 65 holdings, the largest
being DREYFUS GOVERNMENT CASH MANAGE (2.6%), Mirum Pharmaceuticals Inc (2.3%) and Alnylam Pharmaceuticals Inc (2.2%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Exchange | Ticker | Monthly Returns (2 years) |
|---|---|---|---|---|
| Virtus LifeSci Biotech Products ETF | C000148682 | ARCX | BBP |
Holdings
From latest NPORT-P, filed September 27th, 2024 for period ending July 31st, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| ACADIA Pharmaceuticals Inc | Long | Equity-common | US | $415K | 22K | 1.89 |
| ADMA Biologics Inc | Long | Equity-common | US | $375K | 31K | 1.71 |
| AGIOS PHARMACEUTICALS INC | Long | Equity-common | US | $327K | 7K | 1.49 |
| Alnylam Pharmaceuticals Inc | Long | Equity-common | US | $489K | 2K | 2.22 |
| Amgen Inc | Long | Equity-common | US | $367K | 1K | 1.67 |
| Amicus Therapeutics Inc | Long | Equity-common | US | $319K | 31K | 1.45 |
| Apellis Pharmaceuticals Inc | Long | Equity-common | US | $306K | 8K | 1.39 |
| Ardelyx Inc | Long | Equity-common | US | $282K | 51K | 1.28 |
| Ascendis Pharma A/S | Long | Equity-common | DK | $344K | 3K | 1.56 |
| Aurinia Pharmaceuticals Inc | Long | Equity-common | CA | $362K | 62K | 1.65 |
| Axsome Therapeutics Inc | Long | Equity-common | US | $397K | 5K | 1.80 |
| BeiGene Ltd | Long | Equity-common | US | $330K | 2K | 1.50 |
| BioCryst Pharmaceuticals Inc | Long | Equity-common | US | $385K | 53K | 1.75 |
| BIOGEN INC | Long | Equity-common | US | $300K | 1K | 1.36 |
| BIOMARIN PHARMACEUTICAL INC | Long | Equity-common | US | $330K | 4K | 1.50 |
| BioNTech SE | Long | Equity-common | DE | $296K | 3K | 1.34 |
| Blueprint Medicines Corp | Long | Equity-common | US | $335K | 3K | 1.52 |
| Bridgebio Pharma Inc | Long | Equity-common | US | $295K | 11K | 1.34 |
| CRISPR Therapeutics AG | Long | Equity-common | CH | $289K | 5K | 1.31 |
| Day One Biopharmaceuticals Inc | Long | Equity-common | US | $365K | 25K | 1.66 |
| DREYFUS GOVERNMENT CASH MANAGE | Long | Short-term investment vehicle | US | $563K | 563K | 2.56 |
| Dynavax Technologies Corp | Long | Equity-common | US | $307K | 27K | 1.40 |
| Esperion Therapeutics Inc | Long | Equity-common | US | $261K | 113K | 1.19 |
| EXELIXIS INC | Long | Equity-common | US | $352K | 15K | 1.60 |
| Geron Corp | Long | Equity-common | US | $320K | 67K | 1.45 |
| GILEAD SCIENCES INC | Long | Equity-common | US | $394K | 5K | 1.79 |
| HALOZYME THERAPEUTICS INC | Long | Equity-common | US | $367K | 7K | 1.67 |
| Harmony Biosciences Holdings Inc | Long | Equity-common | US | $375K | 11K | 1.70 |
| ImmunityBio Inc | Long | Equity-common | US | $289K | 56K | 1.31 |
| Immunocore Holdings PLC | Long | Equity-common | GB | $329K | 8K | 1.50 |
| INCYTE CORP | Long | Equity-common | US | $342K | 5K | 1.55 |
| Insmed Inc | Long | Equity-common | US | $389K | 5K | 1.77 |
| Intra-Cellular Therapies Inc | Long | Equity-common | US | $379K | 5K | 1.72 |
| IONIS PHARMACEUTICALS INC | Long | Equity-common | US | $396K | 8K | 1.80 |
| Iovance Biotherapeutics Inc | Long | Equity-common | US | $341K | 39K | 1.55 |
| IRONWOOD PHARMACEUTICALS INC | Long | Equity-common | US | $376K | 55K | 1.71 |
| Kiniksa Pharmaceuticals International Plc | Long | Equity-common | US | $467K | 18K | 2.12 |
| Krystal Biotech Inc | Long | Equity-common | US | $376K | 2K | 1.71 |
| Legend Biotech Corp | Long | Equity-common | US | $425K | 8K | 1.93 |
| Lexicon Pharmaceuticals Inc | Long | Equity-common | US | $405K | 180K | 1.84 |
| LIGAND PHARMACEUTICALS INC | Long | Equity-common | US | $441K | 4K | 2.01 |
| Madrigal Pharmaceuticals Inc | Long | Equity-common | US | $338K | 1K | 1.54 |
| Mirum Pharmaceuticals Inc | Long | Equity-common | US | $501K | 12K | 2.28 |
| Moderna Inc | Long | Equity-common | US | $270K | 2K | 1.23 |
| NEUROCRINE BIOSCIENCES INC | Long | Equity-common | US | $342K | 2K | 1.56 |
| Novavax Inc | Long | Equity-common | US | $280K | 22K | 1.27 |
| Omniab Inc/old | Long | Equity-common | US | $0 | 1K | – |
| Omniab Inc/old | Long | Equity-common | US | $0 | 1K | – |
| Phathom Pharmaceuticals Inc | Long | Equity-common | US | $356K | 30K | 1.62 |
| PTC Therapeutics Inc | Long | Equity-common | US | $302K | 9K | 1.37 |
| REGENERON PHARMACEUTICALS INC | Long | Equity-common | US | $346K | 321 | 1.57 |
| Rhythm Pharmaceuticals Inc | Long | Equity-common | US | $358K | 7K | 1.63 |
| Roivant Sciences Ltd | Long | Equity-common | US | $331K | 30K | 1.50 |
| Sage Therapeutics Inc | Long | Equity-common | US | $314K | 29K | 1.43 |
| SAREPTA THERAPEUTICS INC | Long | Equity-common | US | $375K | 3K | 1.70 |
| SpringWorks Therapeutics Inc | Long | Equity-common | US | $302K | 8K | 1.37 |
| Tarsus Pharmaceuticals Inc | Long | Equity-common | US | $241K | 10K | 1.10 |
| TG Therapeutics Inc | Long | Equity-common | US | $388K | 20K | 1.77 |
| THERAVANCE BIOPHARMA INC | Long | Equity-common | KY | $388K | 38K | 1.76 |
| Travere Therapeutics Inc | Long | Equity-common | US | $434K | 45K | 1.97 |
| ULTRAGENYX PHARMACEUTICAL INC | Long | Equity-common | US | $344K | 8K | 1.56 |
| UNITED THERAPEUTICS CORP | Long | Equity-common | US | $359K | 1K | 1.63 |
| VERTEX PHARMACEUTICALS INC | Long | Equity-common | US | $341K | 688 | 1.55 |
| Y-mAbs Therapeutics Inc | Long | Equity-common | US | $336K | 27K | 1.53 |
| Zai Lab Ltd | Long | Equity-common | CN | $318K | 17K | 1.45 |
Address
ETFis Series Trust I
31 West 52nd Street
16th Floor
New York
New York
10019
United States of America
Websites
Directors
Robert S. Tull, Jr.
William J. Smalley
Myles J. Edwards
James A. Simpson
Transfer Agents
The Bank of New York Mellon
Pricing Services
ICE Data Services, Inc.
Bloomberg L.P.
Refinitiv US Holdings Inc.
Custodians
Joint Stock Company Commercial Bank Citibank
The Bank of New York Mellon
The Depository Trust Company
Federal Reserve Bank of New York
Shareholder Servicing Agents
The Bank of New York Mellon
Admins
The Bank of New York Mellon
Virtus ETF Solutions LLC
Brokers
VIRTU AMERICAS LLC
Jane Street Execution Services, LLC